| Financial Year |
March 31 2023 |
| Monetary Funds |
580,741,810.16 |
| Held-for-trading Financial Assets |
42,567,058.17 |
| Notes Receivable |
693,000.00 |
| Accounts Receivable |
450,148,611.50 |
| Advances to Suppliers |
21,932,439.02 |
| Other Receivables |
6,359,210.43 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
452,423,099.52 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
16,136,876.13 |
| Total Current Assets |
1,634,850,975.59 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
62,437,156.25 |
| Fixed Assetes |
579,356,808.99 |
| Under-construction Projects |
33,320,092.50 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
128,186,124.43 |
| R&D expenses |
-- |
| Goodwill |
1,185,501,832.60 |
| Long-Term Deferred and Prepaid Expenses |
1,167,799.37 |
| Deferred Income Tax Assets |
31,652,553.43 |
| Other Non-Current Assets |
8,616,633.82 |
| Sub-Total of Non-Current Assets |
2,243,296,707.43 |
| Total Assets |
3,878,147,683.02 |
| Short-Term Loans |
30,019,500.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
10,744,974.31 |
| Accounts Payable |
166,849,935.08 |
| Accounts Received In Advance |
5,545,897.03 |
| Employee Compensation Payable |
19,507,291.03 |
| Taxes Payable |
16,184,742.55 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
17,584,037.64 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,386,348.44 |
| Other Current Liabilities |
2,655,857.18 |
| Sub-Total of Current Liabilities |
292,251,230.09 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,848,980.74 |
| Deferred Income Tax Liabilities |
46,318,164.07 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
79,218,069.44 |
| Total Liabilities |
371,469,299.53 |
| Paid-In Capital(Or Share Stock) |
543,944,364.00 |
| Capital Surplus |
2,167,593,437.27 |
| Surplus Reserve |
64,504,240.36 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
688,399,240.68 |
| Minority Stockholder's Interest |
32,014,426.84 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,474,663,956.65 |
| Owner's Equity（Stockholder's Equity） |
3,506,678,383.49 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,878,147,683.02 |
